ACIU (ACIU) Stock Price & Analysis
ACIU (ACIU) rose 0.00% to USD 2.23 as of July 25, 2026 at 04:53 UTC, according to Nexqual real-time market data.
ACIU last closed at USD 2.23; the session ranged USD 2.17–2.32 on volume of 384,394 shares. Market capitalization is —, with a 52-week range of USD 2.03–4 (NGM). Source: Nexqual, July 25, 2026 at 04:53 UTC.
Key Statistics (as of July 25, 2026 at 04:53 UTC)
| Price | USD 2.23 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.23 |
| Open | USD 2.23 |
| Day Range | USD 2.17 – 2.32 |
| 52-Week Range | USD 2.03 – 4 |
| Volume | 384,394 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ACIU)
Nexqual's technical model rates ACIU "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:53 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.25 (neutral) |
| vs SMA50 | Below (USD 2.49) |
| MACD | -0.07 (negative) |
Financial Health Score (ACIU)
Nexqual rates ACIU's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:53 UTC.
| Growth | Critical — Revenue -87% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $75M cash vs $4M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -105%, ROA -23.1% |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | USD 13.07 | ▼ 6.58% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.24 | ▼ 2.7% |
| ACRS | Aclaris Therapeutics, Inc. | USD 5.23 | ▼ 6.94% |
| ALEC | Alector, Inc. | USD 1.48 | ▼ 3.27% |
| ADIL | Adial Pharmaceuticals, Inc | USD 2.78 | ▲ 2.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:53 UTC. This page is informational and not investment advice.